Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
405 adverse event reports (+533% vs 2022)
In 2023, 405 adverse event reports were filed for Pneumococcal (Vaxneuvance) in VAERS. This represents 34.1% of all 1,188 reports for this vaccine.
Of these reports, 0 mentioned death, 22 involved hospitalization, 25 required ER visits, and 4 reported disability.
Compared to the average of 265 reports per year for this vaccine, 2023 was above average (+53%).
Year-over-year change: The large change from 2022 likely reflects a ramp-up in vaccination (e.g., new vaccine rollout or expanded eligibility) rather than a change in per-dose risk.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.